NEW YORK, NY -- (MARKET WIRE) -- January 31, 2007 -- China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) today announced that its Chinese subsidiary, Hebei Aoxing Pharmaceutical Group, has received final GMP (Good Manufacturing Practices) certification approval for small volume injectables from the State Food and Drug Administration (SFDA) of the People’s Republic of China.
